Fighter is working on an RSV vaccine for newborns and
now says it has enough data to seek approval from
the FDA. The company plans to submit its findings
by the end of the year. RSV is a
common respiratory virus that typically causes mild, cold like
symptoms, but it can be dangerous for for older
adults and infants. We've seen cases spike in recent
weeks, overwhelming pediatric hospitals. Pfizer's vaccine would be
administered to pregnant women, who then produce antibodies that
are passed on to her newborn. If approved by
the FDA, it would be the first vaccine for 00:00:34.645 --> RSV.